தலைமை எட்வர்ட் கை ஹுவா சோவ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தலைமை எட்வர்ட் கை ஹுவா சோவ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தலைமை எட்வர்ட் கை ஹுவா சோவ் Today - Breaking & Trending Today

SLAS Discovery's June issue on synthetic biology available now

The June edition of SLAS Discovery features the cover article, A Perspective on Synthetic Biology in Drug Discovery and Development Current Impact and Future Opportunities by Florian David, Ph.D. (Chalmers University of Technology, Gothenburg, Sweden), Andrew M. Davis, Ph.D. (AstraZeneca, Cambridge, England, UK). Michael Gossing, Ph.D., Martin A. Hayes, Ph.D., and Elvira Romero, Ph.D., and Louis H. Scott, Ph.D. (AstraZeneca, Gothenburg, Sweden), and Mark J. Wigglesworth, Ph.D. (AstraZeneca, London, England, UK). ....

United States , United Kingdom , City Of , Vastra Gotalands Lan , Louish Scott , Andrewm Davis , Elvira Romero , Michael Gossing , Florian David , Robertm Campbell , Markj Wigglesworth , Edward Kai Hua Chow , Martina Hayes , Phd Chalmers University Of Technology , Society For Laboratory Automation , Application Of Fluorescence Lifetime Technology , Life Sciences Innovation , National University Of Singapore , University Of Dundee , Oak Brook , Synthetic Biology , Drug Discovery , Development Current Impact , Chalmers University , Drug Discovery Unit , High Content Analysis ,

SLAS Technology April issue dives into reactive oxygen species


Oak Brook, IL - The April edition of
SLAS Technology features the cover article Therapeutic Potential of Reactive Oxygen Species: State of the Art and Recent Advances by Valeria Graceffa, Ph.D. (Institute of Technology Sligo, Sligo, Ireland).
The cover article explores the therapeutic potential of reactive oxygen species (ROS) including applications ranging from wound healing and hair growth enhancement, to cancer treatment, stem cell differentiation and tissue engineering. At low concentrations, ROS can be utilized as inexpensive and convenient inducers of tissue regeneration, triggering stem cell differentiation and enhancing collagen synthesis. Recent cancer studies have represented ROS as the Achilles Heels of cancers given their high basal levels, leaving tumoral cells unable to sufficiently handle the additional source of oxidative stress. Because of this, higher doses of ROS are used for targeted killing of tumor cells. Lack of understanding of the technicalit ....

United States , Robertm Campbell , Valeria Graceffa , Edward Kai Hua Chow , Automated Laboratory , Society For Laboratory Automation , Life Sciences Innovation , National University Of Singapore , Phd Institute Of Technology Sligo , Oak Brook , Reactive Oxygen Species , Technology Sligo , Achilles Heel , Versatile Cloud Based Automation Solution , Remote Design , Experiment Protocols , Pediatric Crohn , Disease Patients , Quiescent Disease Treated , Partial Enteral Nutrition , Feasibility Study , Full Scan Mass Spectrometry Analysis , High Throughput Compound Plate Quality Control , Emerging Fluorescence Based Technique , Protein Profiling , Extracellular Vesicles ,

SLAS Discovery special issue


Oak Brook, IL - The April edition of
SLAS Discovery is a special issue on advances in protein degradation curated by guest editors M. Paola Castaldi, Ph.D., and Stewart L. Fisher, Ph.D.
Targeted protein degradation has generated interest within the drug discovery arena due to the inhibition of one particular function of a protein not often delivering the successful results that comes from whole-protein depletion. The pharmacology of PROTACs present challenges, however, namely for the development of orally bioavailable drugs. In the article Target Validation Using PROTACs: Applying the Four Pillars Framework authors Rados?aw P. Nowak, Ph.D., and Lyn H. Jones, Ph.D., describe the application of a translational pharmacology framework (the four pillars) to expedite PROTAC development by informing pharmacokinetic-pharmacodynamic (PKPD) understanding and helping clarify structure-activity relationships. Nowak and Jones hope that the four pillars will serve as a useful guidel ....

United States , Stewartl Fisher , Robertm Campbell , M Paola Castaldi , Edward Kai Hua Chow , Lynh Jones , Society For Laboratory Automation , Life Sciences Innovation , National University Of Singapore , Oak Brook , Validation Using , Four Pillars , Protein Target Engagement , Functional Readout , In Depth Characterization , Targeted Protein Degraders , Small Molecule Induced Ubiquitination , Cell Cycle Dependent Degradation , Four Pillars Framework , How They Were Found , Discover New Ones , Throughput Assay Technologies , Targeted Protein Degradation Therapeutics , Vital Role , Characterizing Novel Protein Degraders , Exciting Novel ,